Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Takeda Pharmaceutical had annual revenue of 4.51T JPY, down -1.66%. Takeda Pharmaceutical had revenue of 1.09T in the quarter ending March 31, 2026, with 3.90% growth.

• Revenue (ttm): 4.51T JPY
• Revenue Growth: -1.66%
• P/S Ratio: 1.85
• Revenue / Employee: 95,807,268 JPY
• Employees: 47,029
• Market Cap: 52.50B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.51T	-75.83B	-1.66%
Mar 31, 2025	4.58T	317.79B	7.45%
Mar 31, 2024	4.26T	236.28B	5.87%
Mar 31, 2023	4.03T	458.47B	12.85%
Mar 31, 2022	3.57T	371.20B	11.61%
Mar 31, 2021	3.20T	-93.38B	-2.84%
Mar 31, 2020	3.29T	1.19T	56.93%
Mar 31, 2019	2.10T	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error